fusidic acid has been researched along with mefloquine in 2 studies
| Studies (fusidic acid) | Trials (fusidic acid) | Recent Studies (post-2010) (fusidic acid) | Studies (mefloquine) | Trials (mefloquine) | Recent Studies (post-2010) (mefloquine) |
|---|---|---|---|---|---|
| 1,742 | 117 | 344 | 71 | 0 | 66 |
| Protein | Taxonomy | fusidic acid (IC50) | mefloquine (IC50) |
|---|---|---|---|
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 2.6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allaire, N; Brickelmaier, M; Frisque, RJ; Gorelik, L; Kartikeyan, R; Lugovskoy, A; Reviriego-Mendoza, MM; Simon, K | 1 |
| Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF | 1 |
1 review(s) available for fusidic acid and mefloquine
| Article | Year |
|---|---|
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplastic Stem Cells | 2022 |
1 other study(ies) available for fusidic acid and mefloquine
| Article | Year |
|---|---|
Identification and characterization of mefloquine efficacy against JC virus in vitro.
Topics: Antiviral Agents; Astrocytes; Cell Line, Transformed; Cells, Cultured; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Mefloquine; Microbial Sensitivity Tests; Models, Molecular; Neuroglia; Simian virus 40; Virus Replication | 2009 |